May 12 (SeeNews) - Romanian state-controlled drug maker Antibiotice [BSE:ATB] said it posted a non-consolidated net profit of 31.139 million lei ($7.907 million/7.051 million euro) in 2014, almost unchanged from 31.381 million lei a year earlier.
Non-consolidated operating profit edged down to 49.526 million lei from 52.297 million lei in 2013, the company said in a bourse filing. Pre-tax profit amounted to 37.363 million lei, up from 34.691 million lei in 2013.
Total revenue edged dropped to 338.977 million lei in 2014 from 342.847 million lei a year earlier.
Its share capital remained the same at 67.134 million lei.
|
2014 (in mln lei) |
Y/Y Change (%) |
2013 (in mln lei) |
Net profit |
31.139 |
-0.77% |
31.381 |
Pre-tax profit |
37.363 |
7.7% |
34.691 |
Operating profit |
49.526 |
-5.3% |
52.297 |
Total revenue |
338.977 |
-1.13% |
342.847 |
Cash and cash equivalents |
17.806 |
70% |
10.488 |
Share capital |
67.134 |
0.0% |
67.134 |
(1 euro = 4.4165 Romanian lei)